Anti Tumor Necrosis Factor Alpha (TNFamp;#945;) Therapy in Ankylosing Spondylitis - Asian Perspective

E-ISSN： 1875-6360|5|3|158-164

ISSN： 1573-3971

Source： Current Rheumatology Reviews, Vol.5, Iss.3, 2009-08, pp. : 158-164

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Anti-Tumor Necrosis Factor-amp;#945; Therapy in Undifferentiated Spondyloarthritis (USpA)

Current Rheumatology Reviews, Vol. 5, Iss. 3, 2009-08 ,pp. : 174-176

Bentham Science Publishers

Access to resources Recommend Favorite

Endothelial dysfunction in ankylosing spondylitis improves after tumor necrosis factor-α blockade

By Syngle Ashit Vohra Kanchan Sharma Anjali Kaur L.

Clinical Rheumatology, Vol. 29, Iss. 7, 2010-07 ,pp. : 763-770

Springer Publishing Company

Access to resources Recommend Favorite

Suspected de novo Hepatitis B in a Patient Receiving Anti-Tumor Necrosis Factor Alpha Therapy for the Treatment of Crohn's Disease

Case Reports in Gastroenterology, Vol. 8, Iss. 1, 2014-01 ,pp. : 44-50

Karger

Access to resources Recommend Favorite

Demyelination during anti-TNFα therapy for ankylosing spondylitis

By Mercieca Cecilia

Modern Rheumatology, Vol. 22, Iss. 2, 2012-04 ,pp. : 303-307

Springer Publishing Company

Access to resources Recommend Favorite

Anti-TNF-αα therapy for ankylosing spondylitis

By Frech Tracy

Future Rheumatology, Vol. 2, Iss. 5, 2007-10 ,pp. : 515-520

Future Medicine

Access to resources Recommend Favorite